Overview

Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®

Status:
Active, not recruiting
Trial end date:
2021-02-11
Target enrollment:
Participant gender:
Summary
The purpose of this dose finding/comparative efficacy study is to first single out the most appropriate dose of mannitol for bowel preparation (phase II) and, subsequently, demonstrate the non-inferiority of the efficacy of mannitol vs standard split 2L PEG ASC (Moviprep®) (phase III) in bowel preparation for colonoscopy .
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
NTC srl